Vamsidhar Adhinarayan
I am a sustainability and ESG professional with close to four years of experience across strategy consulting and commercial analytics. At PwC India, I have advised organisations across the BFSI, healthcare, and infrastructure sectors on ESG strategy, regulatory compliance, and sustainability disclosures. My work spans ESG maturity assessments, carbon reduction roadmaps, sustainable finance frameworks, and board-level advisory. I led India's first NBFC to disclose Scope 3 financed emissions and was recognised with the PwC Chairperson's Award in 2025 for my contribution to a significant multi-year client mandate. Prior to PwC, I worked at PharmaAce Analytics supporting commercial strategy and demand forecasting for oncology brands. I hold published research in peer-reviewed journals on biotechnology and sustainability themes. At XLRI, I aim to deepen my expertise in strategic leadership and general management to drive transformation at the intersection of business, policy, and sustainability.
Work experience
45 months in total
- PricewaterhouseCoopers Pvt Ltd33 months
- PharmaAce Analytics Pvt Ltd11 months
Career highlights
Associate Consultant, ESG Advisory, PwC India
- Advised clients across the BFSI sector on ESG strategy, disclosure frameworks, and regulatory compliance, translating requirements under SEBI BRSR, GRI, and DJSI into structured roadmaps.
- Led India's first NBFC through Scope 3 financed emissions disclosure, navigating regulatory interpretation and coordinating across multiple internal and external stakeholders.
- Assessed ESG performance across client value chains, designing frameworks to evaluate supplier practices and developing improvement plans to raise overall compliance standards.
- Conducted human rights risk assessments for clients, identifying exposure across operations and value chains and recommending mitigation measures aligned to international reporting standards.
Business Development, PwC India
- Identified opportunities to expand scope across ongoing ESG engagements and supported the growth of the firm's ESG advisory practice through proposals and senior-level client management.
- Secured repeat projects through sustained delivery quality and CXO-level relationship management, recognised with the PwC Chairperson's Award in 2025.
Analyst, Forecasting, PharmaAce Analytics
- Supported commercial strategy and demand forecasting for oncology brands by analysing market data to surface insights on competitive dynamics and revenue planning.
- Contributed to the product development of the firm's in-house analytics platform, working cross-functionally to define features and improve the quality of client deliverables.
Achievements
- PwC Chairpersons Award 2025
- Culture Catalyst Award
Certifications
- CII Certified: GHG Carbon Footprint (Nov 2024)
- CII Certified: Resource Efficiency and Waste Management (Jun 2024)
- Google: Foundations of Project Management (Jun 2021)
- Wharton School, UPenn: Business Strategies for Social Impact (Aug 2021)
- University of London: Global Energy and Climate Policy (Sep 2020)
